Luye Pharma Group Ltd. reported an EPS of $0.014 in its last earnings report, beating expectations of $0.014. Following the earnings report the stock price went same 0%.

2 Followers

LYPHF Stock Chart & Stats

Advanced Chart >

Day’s Range$0 - $0

52-Week Range$0.31 - $0.53

Previous Close$0.33

Volume1.00K

Average Volume (3M)1.00K

Market Cap

$1.23B

Enterprise Value$1.82B

Total Cash (Recent Filing)¥5.57B

Total Debt (Recent Filing)¥9.19B

Price to Earnings (P/E)16.7

Beta0.10

Next Earnings

Aug 28, 2024

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.02

Shares OutstandingN/A

10 Day Avg. Volume0

30 Day Avg. Volume1,000

Standard Deviation0.16

R-Squared0.02

Alpha-0.19

Financial Highlights & Ratios

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

Price to Cash Flow (P/CF)N/A

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

$0.34

Price Target Upside-11.97% Downside

Rating ConsensusModerate Sell

Number of Analyst Covering1

Financials

Annual

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

33.43%

Insiders

1.96% Mutual Funds

2.17% Other Institutional Investors

62.44% Public Companies and

Individual Investors

Detailed Ownership Overview >

LYPHF FAQ

What was Luye Pharma Group Ltd.’s price range in the past 12 months?

Luye Pharma Group Ltd. lowest stock price was $0.30 and its highest was $0.53 in the past 12 months.

What is Luye Pharma Group Ltd.’s market cap?

Currently, no data Available

When is Luye Pharma Group Ltd.’s upcoming earnings report date?

Luye Pharma Group Ltd.’s upcoming earnings report date is Aug 28, 2024 which is in 125 days.

How were Luye Pharma Group Ltd.’s earnings last quarter?

Luye Pharma Group Ltd. released its earnings results on Mar 27, 2024. The company reported $0.014 earnings per share for the quarter, beating the consensus estimate of $0.014 by <$0.001.

Is Luye Pharma Group Ltd. overvalued?

According to Wall Street analysts Luye Pharma Group Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Luye Pharma Group Ltd. pay dividends?

Luye Pharma Group Ltd. does not currently pay dividends.

What is Luye Pharma Group Ltd.’s EPS estimate?

Luye Pharma Group Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Luye Pharma Group Ltd. have?

Luye Pharma Group Ltd. has 3,761,670,700 shares outstanding.

What happened to Luye Pharma Group Ltd.’s price movement after its last earnings report?

Luye Pharma Group Ltd. reported an EPS of $0.014 in its last earnings report, beating expectations of $0.014. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Luye Pharma Group Ltd.?

Currently, no hedge funds are holding shares in LYPHF

---

Luye Pharma Group Stock Smart Score

Underperform

Analyst Consensus

Moderate Sell

Average Price Target:
$0.34 (-11.97% Downside)

Technicals

Fundamentals

Return on Equity

4.61%

Trailing 12-Months

Asset Growth

3.04%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Luye Pharma Group Ltd.

Luye Pharma Group Ltd is a major drug manufacturer that focuses on developing, producing, and selling pharmaceutical products. The company's operations are primarily centered in China with treatments focused on oncology, cardiovascular diseases, and metabolism. The vast majority of the company's revenue is generated from oncology drugs, followed by cardiovascular drugs. Luye's growth strategies include continued innovation and globalization while improving its market share in China in the three key therapeutic areas, namely oncology, cardiovascular system and alimentary tract, and metabolism. In addition, Luye intends to strengthen international cooperation while accelerating the launch of product candidates internationally.

---

LYPHF Stock 12 Months Forecast

Average Price Target

$0.34

▼(-11.97% Downside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"plus_tr_sans","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","1":"$1","-1":"-$1","-0.5":"-$0.5","0.5":"$0.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":0.344708055,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$0.34</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.34,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$0.34</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.344708055,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$0.34</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.5,0,0.5,1],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2023","6":"Nov<br/>2023","9":"Jan<br/>2024","12":"Apr<br/>2024","25":"Apr<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.34,0.3403621580769231,0.3407243161538462,0.34108647423076927,0.34144863230769235,0.3418107903846154,0.3421729484615385,0.34253510653846153,0.3428972646153846,0.3432594226923077,0.34362158076923077,0.34398373884615385,0.34434589692307693,{"y":0.344708055,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.34,0.34,0.34,0.34,0.34,0.34,0.34,0.34,0.34,0.34,0.34,0.34,0.34,{"y":0.34,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.34,0.3403621580769231,0.3407243161538462,0.34108647423076927,0.34144863230769235,0.3418107903846154,0.3421729484615385,0.34253510653846153,0.3428972646153846,0.3432594226923077,0.34362158076923077,0.34398373884615385,0.34434589692307693,{"y":0.344708055,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.49,"date":1682899200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.44,"date":1685577600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.42,"date":1688169600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.46,"date":1690848000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.37,"date":1693526400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.44,"date":1696118400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.48,"date":1698796800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.5,"date":1701388800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.48,"date":1704067200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.42,"date":1705017600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.32,"date":1706832000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.37,"date":1709251200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.34,"date":1712275200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >

Technical Analysis

Similar Stocks

Astellas Pharma

―

BAYRY

Bayer

―

KOD

Kodiak Sciences

―

BHC

Bausch Health Companies

―

Compare LYPHF Stocks >

Best Analysts Covering LYPHF

1 Year

Sean Wu CFAMorgan Stanley

1 Year Success Rate

3/3 ratings generated profit

1 Year Average Return

+41.57%

reiterated a sell rating 25 days ago

Copying Sean Wu CFA's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +41.57% per trade.

Best Analyst Covering >

Popular Stocks

---

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing